101
Participants
Start Date
December 19, 2017
Primary Completion Date
April 30, 2026
Study Completion Date
February 18, 2029
Avelumab
Given IV
Peripheral Blood Collection
Correlative studies
Placebo
Given IV
Memorial Sloan Kettering Cancer Center, New York
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill
Moffitt Cancer Center, Tampa
University of Michigan Comprehensive Cancer Center, Ann Arbor
Northwestern University, Chicago
University of Colorado Cancer Center University of Colorado Anschutz Medical Campus, Aurora
University of California Irvine Chao Family Comprehensive Cancer Center, Orange
Fred Hutch/University of Washington Cancer Consortium, Seattle
Dana Farber Cancer Institute, Boston
Collaborators (1)
EMD Serono
INDUSTRY
University of Washington
OTHER